Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,747,845
-
Total 13F shares
-
759,748
-
Share change
-
+24,505
-
Total reported value
-
$2,272,531
-
Price per share
-
$2.98
-
Number of holders
-
27
-
Value change
-
+$89,233
-
Number of buys
-
6
-
Number of sells
-
6
Institutional Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q3 2025
As of 30 Sep 2025,
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
759,748 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, EDGEWOOD MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, SeaCrest Wealth Management, LLC, Grey Ledge Advisors, LLC, BlackRock, Inc., and NORTHERN TRUST CORP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.